J
Julia Chalaye
Researcher at University of Paris
Publications - 27
Citations - 850
Julia Chalaye is an academic researcher from University of Paris. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 10, co-authored 24 publications receiving 600 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valérie Vilgrain,Valérie Vilgrain,Helena Pereira,Eric Assenat,Boris Guiu,Alina Diana Ilonca,Georges-Philippe Pageaux,Annie Sibert,Mohamed Bouattour,Rachida Lebtahi,Wassim Allaham,Hélène Barraud,Valérie Laurent,Elodie Mathias,Jean-Pierre Bronowicki,Jean-Pierre Tasu,Rémy Perdrisot,Christine Silvain,René Gerolami,Olivier Mundler,Jean-François Seitz,Vincent Vidal,Christophe Aubé,Frédéric Oberti,Olivier Couturier,Isabelle Brenot-Rossi,Jean-Luc Raoul,Anthony Sarran,Charlotte Costentin,Emmanuel Itti,Alain Luciani,Alain Luciani,René Adam,Maïté Lewin,Didier Samuel,Maxime Ronot,Maxime Ronot,Aurelia Dinut,Laurent Castera,Laurent Castera,Gilles Chatellier,Gilles Chatellier,Elisabeth Delhom Christol,Alina D. Ilonca,Julie Lonjon,Mohamed Abdel-Rehim,Arnaud Dieudonné,Christophe Bazin,Carine Chagneau-Derrode,Patrick Borentain,Antoine Bouvier,Laurent Vervueren,Julia Chalaye,Hicham Kobeiter,Julien Edeline,Etienne Garin,Yan Rolland,Isabelle Archambeaud,T. Eugène,Eric Frampas,Christophe Cassinotto,Martine Guyot,Jean-Baptiste Hiriart,Bruno Lapuyade,Julien Vergniol,Philippe Bachellier,Julien Detour,Bernard Duclos,Michel Greget,Francois Habersetzer,Alessio Imperiale,Philippe Merle,Agnès Rode,Julie Morvan,Eric Nguyen-Khac,Thierry Yzet,G. Baudin,Patrick Chevallier,Abakar Mahamat,Thierry Piche,Micheline Razzouk,Patrick Hillon,Romaric Loffroy,Michel Toubeau,Julie Vincent,Gabriele Barabino,Nadia Bouarioua,Muriel Cuilleron,Marie Ecochard,Nathalie Prevot-Bitot,Vincent Leroy,J. Roux,Christian Sengel,Valérie Bourcier,Nathalie Ganne-Carrié,Olivier Seror,Sylvie Costo,Thong Dao,Jean-Pierre Pelage,Jérôme Dumortier,Francesco Giammarile,Pierre-Jean Valette,Nadia Ghazzar,Olivier Pellerin,Julien Taieb,Pierre Weinmann,Alexandra Heurgue-Berlot,Claude Marcus,Daniele Sommacale,Maria-Angéla Castilla-Lièvre,Sophie Maitre,Lysiane Marthey +111 more
TL;DR: SarAH was a multicentre, open-label, randomised, controlled, investigator-initiated, phase 3 trial done at 25 centres specialising in liver diseases in France to compare the efficacy and safety of sorafenib to that of selective internal radiotherapy in patients with hepatocellular carcinoma.
Journal ArticleDOI
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
Julia Chalaye,Charlotte Costentin,Alain Luciani,Giuliana Amaddeo,Nathalie Ganne-Carrié,Laurence Baranes,Manon Allaire,Julien Calderaro,Daniel Azoulay,Pierre Nahon,Pierre Nahon,Olivier Seror,Ariane Mallat,Michael Soussan,Christophe Duvoux,Emmanuel Itti,Jean-Charles Nault,Jean-Charles Nault +17 more
TL;DR: When used for HCC staging, dual-tracer PET/CT enabled BCLC upgrading and treatment modification in 11% and 14% of patients, respectively.
Journal ArticleDOI
[18F]-NaF PET/CT imaging in cardiac amyloidosis
Axel Van Der Gucht,Arnault Galat,Jean Rosso,Aziz Guellich,Jérôme Garot,Diane Bodez,Violaine Planté-Bordeneuve,Luc Hittinger,Jean-Luc Dubois-Randé,Eva Evangelista,Myriam Sasanelli,Julia Chalaye,Michel Meignan,Emmanuel Itti,Thibaud Damy +14 more
TL;DR: The role of [18F]-sodium fluoride (NaF) PET/CT is emphasized as a potential noninvasive tool to identify and differentiate the transthyretin-related cardiac amyloidosis from the light-chain cardiac amymoidosis.
Journal ArticleDOI
18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: A prospective observational study
Chetana Lim,Chady Salloum,Julia Chalaye,Eylon Lahat,Charlotte Costentin,Michael Osseis,Emmanuel Itti,Cyrille Feray,Daniel Azoulay +8 more
TL;DR: 18F-FDG PET/CT predicts MVI and early recurrence after surgery for HCC and could be used to select patients for neoadjuvant treatment.
Journal ArticleDOI
Clinical impact of contrast-enhanced computed tomography combined with low-dose (18)F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management.
Julia Chalaye,Alain Luciani,Catalina Enache,Pauline Beaussart,Catherine Lhermite,Eva Evangelista,Myriam Sasanelli,Violaine Safar,Michel Meignan,Corinne Haioun,Alain Rahmouni,Emmanuel Itti +11 more
TL;DR: The clinical impact of CECT seems limited, although scarce, life-threatening conditions were diagnosed, and Imaging of lymphoma needs optimization to reduce radiation exposure.